Organizing Committee
OCM Member
Touro College of Pharmacy , USA
Biography :

Mariana Babayeva MD, PhD is an Associate Professor at Touro College of Pharmacy, New York, NY. In addition to her role at Touro, Dr. Babayeva is also an Adjunct Professor at Rockefeller University and Visiting Scientist at Arnold and Marie Schwartz School of Pharmacy of LIU. Dr. Babayeva has over 14 years of experience in clinical practice. She is recognized for her expertise in the pharmacokinetics and the use of animal and organ models. Dr. Babayeva has conducted several international research projects. Dr. Babayeva has been published in peer-reviewed journals and serving as an editorial board member of repute.

OCM Member
Howard University , USA
Biography :

Emmanuel O. Akala, R. Ph., Ph.D. is a Professor of Pharmaceutics, Chair, Howard University Institutional Animal Care and Use Committee (IACUC) and Director, Laboratory for Nanomedicine, Drug Delivery, and Pharmaceutical & Biopharmaceutical Drug Products Design. His training is cosmopolitan and his curriculum vitae (CV) provides details of his professional training as a pharmacist and an immunization pharmacist (registered in Utah, Maryland, Washington DC and in Nigeria), a pharmacy professor, and a research scientist with bias for conventional and novel drug delivery systems. Professor Akala received B. Pharm. (Hons) degree and M.Sc. (Pharmaceutics) degree at The University of Ife (Now Obafemi Awolowo University), Ile-Ife, Nigeria and Ph.D. degree in Pharmaceutics at The University of Manchester, England (as a Commonwealth Scholar). He was a DAAD Fellow at the Institute of Biopharmaceutics and Pharmaceutical Technology, University of Munster, Germany, and an NIH Postdoctoral Fellow in Pharmaceutics and Bioengineering at The University of Utah, USA. He has worked as a pharmacist in Nigeria and USA, and as a Lecturer and Senior Lecturer in Pharmaceutics in Nigeria, as a Teaching Assistant in England, as a Laboratory Instructor and Research Associate in USA and Germany and as an Assistant Professor, Associate Professor and Professor of Pharmaceutics in USA. Professor Akala has established a very active research group with capability for the design and development of conventional and novel drug products/drug delivery systems. His research focus, at the moment, is on nanotechnology platform for the treatment of cancer and HIV/AIDS with the applications of quality by design (QbD), statistical experimental design, computer optimization, and process analytical technology in his research efforts. At Howard University, he has obtained more than ten million dollars in research grants. His current research grant funding is as follows: (1) NIH/NCI (Akala (PI): Novel Nanotechnology Platform for Breast Cancer Treatment ($1,132,500:00: 2015 -2018). (2) NIH/NIAID (Akala (PI):The District of Columbia Center for AIDS Research: Targeting Drug (ARV) Loaded Multifunctional Nanoparticles to M Cells Overlaying GALT (HIV-1 Reservoir) ($600,000:00: 2011 -2016). (3). U.S. ? Russian University Research Competition (CRDF Global - Peace and Prosperity Through Science Collaboration PI: ($110,000) (June 1, 2015 – May 31, 2017). Professor Akala holds three patents. He has numerous research publications in peer reviewed journals and several conference proceedings and abstracts. In the HU College of Pharmacy, Professor Akala was the Chairman of the Practice and Physical Facilities Sub-Committee (twice) during the reaccreditation programs. He initiated the survey of our external preceptors to substantiate the contents of our accreditation dossier. He was the Chairman of the Admission, Recruitment and Retention Committee. He initiated changing of our maths admission questions every year; we continue the tradition till today. He has served and/or chaired varied and diverse committees in his Department, HU College of Pharmacy, Howard University, and nationally & internationally. Over the years, Professor Akala has taught several Pharm. D. courses and has developed and taught several Ph.D. courses and mentored several Doctor of Pharmacy students. He has directed the research work of eight M.S. students, four Ph.D. students, eight postdoctoral fellows, several Pharm. D., B.S., and high school students and four pharmacy students from different Universities in Brazil (Brazil Scientific Mobility Program). His research endeavors have been characterized by wide interactions and associations (interdisciplinary approach to research) at Howard University, within USA and in Germany, UK and Demark. Professor Akala received the 2013 Distinguished Howard University College of Pharmacy Alumni Award, the 2013 Top Reviewer Award in the Journal of Pharmaceutical Sciences, the 2013 Top Reviewer Award in the Journal of Nanomedicine, the 2014 AACR Minority-Serving Institution Faculty Scholar in Cancer Research Award, and the 2016 Washington DC Pharmacy Association NASPA Excellence in Innovation Award. Professor Akala has been serving as a member of the Advisory Group of the Center for Pharmaceutical Advancement and Training of the United States Pharmacopeia since 2013. He was appointed, in 2015, a member of the USP (the General Chapters-Dosage Forms USP’s Expert Committee). USP Expert Committees are responsible for developing and revising USP standards that comprise its compendia: the USP and the NF, USP Compounding Compendium, Herbal Medicines Compendium, Dietary Supplements Compendium, and Food Chemicals Codex.

OCM Member
University of Copenhagen , Denmark
Biography :

Steen Honoré Hansen obtained his degree in pharmacy from The Royal Danish School of Pharmacy in Copenhagen, Denmark. After graduation he worked for four years in a department for analytical chemical research at Dumex Ltd, Copenhagen. In 1975 he came to the Royal Danish School of Pharmacy, Dept of Organic Chemistry as an assistant professor. In 1977 he became an associate professor in Analytical Chemistry of which he became full professor in 1993. He obtained his D.Sc. degree in separation science in 1990 and he is now at the group of analytical biosciences, Department of Pharmacy, The Faculty of Health and Medical Sciences, University of Copenhagen. His main research interests are within basic separation sciences (primarily HPLC and CE) in particular on separation mechanisms but also extended into hyphenated techniques using MS, NMR and ICP-MS besides conventional detection techniques. New techniques and methods are applied in bioanalysis and in drug metabolism. In drug metabolism focus has been on reactive drug metabolites and their possible role in idiosyncratic reactions. His is the author or co-author of more than 330 papers in international peer-review journals. For 20 years he was the President of the Scandinavien Section of The Chromatographic Discussion Group until this was changed into the Separation Sciences Foundation. He has been involved in the arrangement of a major number of national and international conferences, lately as the chair of the 26th International Symposium in Chromatography. His has been involved in administrative duties as the Head of Department of Chemistry for three years and Head of Dept. of Analytical Chemistry for six years. Furthermore his has been a member of the Board as well as of the Board of Research for the Royal Danish School of Pharmacy.

OCM Member
University of Louisiana Monroe , USA
Biography :

Ronald A. Hill, B.S.Chem., Ph.D., is a native of central Ohio. He graduated from the University of Michigan in 1982 with a B.S.Chem. degree, completing an honors thesis project in mechanistic organic chemistry with Professor Peter A. S. Smith. He then spent 4-1/2 years engaged in analytical chemistry and biopharmaceutics R&D at the Upjohn Company in Kalamazoo, MI, followed by graduate study at The Ohio State University, where he completed a Ph.D. in Pharmacy, with emphases in synthetic medicinal and computational chemistry. His graduate research was directed by Professors Duane D. Miller and Jan K. Labanowski (Ohio Supercomputer Ctr.). In 1991, he established a research group at ULM, mainly engaged in areas of synthetic medicinal and bioanalytical chemistry. Historically, his research, funded at various times by the NIH and the AHA, focused mostly on projects related to the central nervous system, particularly the efficient delivery of small organic molecules to the CNS and their distribution, biotransformation, and actions therein. Over the years, he also collaborated extensively with investigators working in areas of pharmaceutics, toxicology, pharmacology, and clinical sciences, and also gained extensive acumen in molecular therapeutics design, molecular biopharmaceutics, and molecular toxicology. His more-recent educational duties at the Ph.D. and Pharm.D. levels, and ongoing research collaborations in areas including cancer and Alzheimer’s disease, has demanded even more breadth and depth of knowledge, especially in areas bridging early discovery science to clinical application. He also currently serves as a member of the Expert Panel for the Cosmetic Ingredient Review, a key safety assessment body for non-drug personal care products. He has served as major adviser for a number of M.S. and Ph.D. students, and on the graduate committees of now more than 60 others, all of whom have an admirable record of accomplishment in industry, government, or academia.

OCM Member
West Coast University , USA
Biography :

Dr. Giri, is currently working as Assistant Professor at Center for Graduate Studies, West Coast University. Dr. Giri received her Bachelor of Pharmacy degree from Shri G.S Institute of Science and Technology and Master of Pharmaceutical Biotechnology from Dr. H.S. Gour University in India. She subsequently earned her PhD in Pharmaceutical Sciences from the University of Missouri-Kansas City. Her primary teaching area is pharmaceutics; her research interests include novel drug delivery, nanotechnology-based drug delivery, and mucosal delivery of microbicides. She currently serves as editorial board member and reviewer for more than five peer-reviewed scientific journals.

Research Interest :

Novel Drug Delivery,Nano technology-Based Drug Delivery,Mucosal Delivery of Microbicides

OCM Member
Universiteit Antwerpen , Belgium
Biography :

Stuart Maudsley has been recognized as a visionary pioneer in science (both physical and biomedical) from childhood where his work was publicized on the national television program ‘The Power Game’ – a U.K. wide engineering Olympiad. Stuart has been subsequently awarded and recognized throughout his career as both an intellectual innovator and as an excellent scientist. Stuart’s primary contribution to science is in the field of receptor systems biology and pharmacotherapeutics design – within this field Stuart is one of the world’s leading young Investigators. Stuart graduated from the University of Leeds with First Class Honors in Pharmacology and was awarded the Pfizer Prize for undergraduate research. For his doctoral work Stuart was one of only 6 recipients (from a University population of 40,000) of the Universities venerated ‘Named Scholarships’, i.e. the Ackroyd, Brotherton and Brown Scholarship. After gaining his Ph.D. in Receptor Pharmacology, he was then awarded a Howard Hughes Medical Institute Fellowship Award to train with Professor Robert Lefkowitz (2012 Nobel Laureate in Chemistry) at Duke University. Following this fellowship Stuart was instantly recruited to be Principal Investigator of the Receptor Biology Section at the Medical Research Council (MRC) -Human Reproductive Sciences Unit at the University of Edinburgh. During his time at the MRC his drug discovery and development abilities was implicit in his recruitment as a scientific advisor to Ardana Bioscience Inc. where he subsequently developed a novel prostate cancer therapeutic. To broaden his already considerable biomedical experience Stuart then accepted the position of Head of the Receptor Pharmacology Unit at the National Institutes of Health (NIH-National Institute on Aging) at the Johns Hopkins University Medical Center.

Research Interest :

Biomedical Research,Molecular Genetics

Mail us at

For General Queries
drugdiscovery@alliedconferences.org
For Regsirtation Queries
drugdiscovery@alliedmeetings.com
For Exhibitior Queries
drugdiscovery@alliedconferences.org
More details about sponsorship:sponsors@alliedacademies.com

Terms and Conditions

Responsibility

Delegates are personally responsible for their belongings at the venue. The Organizers will not be held responsible for any stolen or missing items belonging to Delegates, Speakers or Attendees; due to any reason whatsoever.

Insurance

Registration fees do not include insurance of any kind.

Transportation

Please note that any (or) all transportation and parking is the responsibility of the registrant.

Press/Media

Press permission must be obtained from Allied Academies Conferences Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The Allied Academies is an objective third-party nonprofit organization. This conference is not associated with any commercial meeting company.

Requesting an Invitation Letter

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference. Once your registration is complete, please contact drugdiscovery@alliedconferences.org to request a personalized letter of invitation.

Regarding refunds, all bank charges will be for the registrants account.

This cancellation policy was last updated on December 12, 2016.

Cancellation, Postponement and Transfer of Registration

All cancellations or modifications of registration must be made in writing to drugdiscovery@alliedconferences.org

Cancellation Policy

If Allied Academies cancels this event for any reason, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied Academies event which must occur within one year from the date of cancellation.

Postponement

If Allied Academies postpones an event for any reason and you are unable or unwilling to attend on rescheduled dates, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied Academies event which must occur within one year from the date of postponement.

Transfer of registration

All fully paid registrations are transferable to other persons from the same organization, if registered person is unable to attend the event. Transfers must be made by the registered person in writing to drugdiscovery@alliedconferences.org . Details must be included the full name of replacement person, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied Academies if the person is unable to attend one of conferences.

However, Registration cannot be transferred if it is intimated within 14 days of respective conference.

The transferred registrations will not be eligible for Refund.

Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied Academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues cannot come under the consideration of cancellation policy of Allied Academies, including the inability to obtain a visa.

Refund Policy:

If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund arrangements apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overheads, we had to keep Refund Policy is as following slabs-

  • Before 60 days of the conference: Eligible for Full Refund less $100 service Fee
  • Within 60-30 days of Conference: Eligible for 50% of payment Refund
  • Within 30 days of Conference: Not eligible for Refund
  • E-Poster Payments will not be refunded.

Accommodation Cancellation Policy:

Accommodation Providers (Hotels) have their own cancellation policies, and they generally apply when cancellations are made less than 30 days prior to arrival. Please contact us as soon as possible, if you wish to cancel or amend your accommodation. Allied Academies will advise the cancellation policy of your accommodation provider, prior to cancelling or amending your booking, to ensure you are fully aware of any non-refundable deposits.

 

Copyright © 2017-2018 Allied Academies, All Rights Reserved.